JP2018527103A - Intelligent continuous production method of drop pills by liquid cooling - Google Patents
Intelligent continuous production method of drop pills by liquid cooling Download PDFInfo
- Publication number
- JP2018527103A JP2018527103A JP2018513526A JP2018513526A JP2018527103A JP 2018527103 A JP2018527103 A JP 2018527103A JP 2018513526 A JP2018513526 A JP 2018513526A JP 2018513526 A JP2018513526 A JP 2018513526A JP 2018527103 A JP2018527103 A JP 2018527103A
- Authority
- JP
- Japan
- Prior art keywords
- liquid
- temperature
- drop
- pills
- cooling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006187 pill Substances 0.000 title claims abstract description 81
- 238000000034 method Methods 0.000 title claims abstract description 35
- 239000007788 liquid Substances 0.000 title claims abstract description 34
- 238000001816 cooling Methods 0.000 title claims abstract description 24
- 238000010924 continuous production Methods 0.000 title claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 109
- 238000004519 manufacturing process Methods 0.000 claims abstract description 30
- 238000002156 mixing Methods 0.000 claims abstract description 20
- 239000000110 cooling liquid Substances 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 238000005303 weighing Methods 0.000 claims abstract description 8
- 239000002826 coolant Substances 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 238000000265 homogenisation Methods 0.000 claims abstract description 5
- 238000005119 centrifugation Methods 0.000 claims abstract description 4
- 238000002844 melting Methods 0.000 claims abstract description 3
- 230000008018 melting Effects 0.000 claims abstract description 3
- 230000008569 process Effects 0.000 claims description 13
- 230000001133 acceleration Effects 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 7
- 241000544061 Cuculus canorus Species 0.000 claims description 6
- 239000011159 matrix material Substances 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 239000012188 paraffin wax Substances 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 239000003350 kerosene Substances 0.000 claims description 2
- 239000000832 lactitol Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 2
- 235000010448 lactitol Nutrition 0.000 claims description 2
- 229960003451 lactitol Drugs 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 241000978776 Senegalia senegal Species 0.000 claims 1
- YDLQKLWVKKFPII-UHFFFAOYSA-N timiperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCC(N2C(NC3=CC=CC=C32)=S)CC1 YDLQKLWVKKFPII-UHFFFAOYSA-N 0.000 claims 1
- 229950000809 timiperone Drugs 0.000 claims 1
- 229940057995 liquid paraffin Drugs 0.000 description 21
- 239000000203 mixture Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000008118 PEG 6000 Substances 0.000 description 5
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 4
- 239000005662 Paraffin oil Substances 0.000 description 4
- 229940116229 borneol Drugs 0.000 description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 238000007872 degassing Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 241000722363 Piper Species 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 239000001738 pogostemon cablin oil Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
【課題】
【解決手段】1)複数の材料をそれぞれ秤量して搬送する、材料供給ステップ、2)ステップ1)で搬送された前記材料を段階的に加熱しかつ混合することによって混合材料が得られ、前記混合材料中の有効成分RSDが5%以下である、材料熔解混合ステップ、3)ステップ2)で得られた混合材料を加圧および昇温して、有効成分RSDが5%以下である均質化材料が得られる、均質化ステップ、4)ステップ3)で得られた均質化材料を振動滴下した後に滴丸剤が得られ、滴丸剤を冷却液に投入して冷却した後に搬送する、滴下ステップ、5)ステップ4)で搬送された滴丸剤の表面の冷却液を傾斜遠心法によって除去する、脱油ステップを含む液体冷却による滴丸剤のインテリジェント連続製造方法である。該製造方法は、全体的な製造過程の時間を短縮するだけでなく、滴丸剤製品が安定性および均一性をさらに有するように確保し、かつ高速遠心法を採用することによって合理的に滴丸剤を脱油して、滴丸剤が汚染されることを防止するのみでなく、冷却液の循環利用率も向上させる。【Task】
A material supply step for weighing and conveying a plurality of materials, and 2) heating and mixing the materials conveyed in step 1) in stages to obtain a mixed material, The active ingredient RSD in the mixed material is 5% or less, the material melting and mixing step, 3) pressurizing and raising the temperature of the mixed material obtained in step 2), and homogenizing the active ingredient RSD being 5% or less A material is obtained, a homogenization step, 4) A drop pill is obtained after vibrationally dropping the homogenized material obtained in step 3), a drop pill is poured into a cooling liquid and cooled and then transported. Step 5) An intelligent continuous production method of liquid pills by liquid cooling including a deoiling step in which the cooling liquid on the surface of the liquid pills conveyed in Step 4) is removed by a tilted centrifugation method. The manufacturing method not only shortens the overall manufacturing process time, but also ensures that the drop pill product is more stable and uniform and adopts a high speed centrifuge method to rationalize the drop. Not only does the pills be deoiled to prevent the pills from becoming contaminated, but also improves the circulating utilization of the coolant.
Description
本発明は、製薬技術分野に関し、特に滴丸剤類の薬剤製造設備に関し、具体的には液体冷却による滴丸剤のインテリジェント連続製造方法に関する。 The present invention relates to the field of pharmaceutical technology, and more particularly to a drug production facility for drop pills, and more particularly to an intelligent continuous production method for drop pills by liquid cooling.
滴丸剤は、漢方薬製剤における伝統的な剤形であり、その生産サイクルが短く、薬の効果が速く、薬剤の安定性が高く、かつ携帯保管に便利であるなどの多くの長所により、広く支持を得ている。 Drip pills are a traditional dosage form in Chinese herbal medicines, which are widely used due to many advantages such as short production cycle, fast drug effect, high drug stability and convenient for portable storage. Get support.
従来の滴丸剤の生産方法は、基本的に自然滴下と液体冷却を組み合わせたものであるか、または自然滴下法から改良された加圧滴下法と液体冷却を組み合わせたものであり、従来技術の方法の短所は以下の通りである。1、全体的な製造過程に長い時間がかかり、原料中に含まれる一部の揮発性成分が成分揮発を招くため、滴丸剤製品の品質の均一性や安定性を保証し難い。2、材料供給システムが存在せず、滴丸剤中の有効成分の均一度の低下を招く。3、さらに、液体冷却方法を採用して、滴丸剤および冷却液の液固分離を行う必要があるが、両者を徹底的に分離することは操作が比較的に困難であるため、冷却液が滴丸剤に残留することを避け難く、滴丸剤の汚染を招く。4、生産量の調整が必要な場合に、従来の滴下設備は一般的にドリッパーの変更および圧力の調整によってのみ可能であり、滴下回数が少なく、加えて大量のパラフィン冷却液で表面積を熱交換する必要があり、循環効率が低く、エネルギー消費が大きく、設備体積の増大を招き、清潔面における死角が存在しやすく、相互汚染のリスクが大きい。 Conventional methods for producing drop pills are basically a combination of natural dripping and liquid cooling, or a combination of a pressure drop method improved from the natural dripping method and liquid cooling. The disadvantages of this method are as follows. 1. Since the entire production process takes a long time and some volatile components contained in the raw material cause component volatilization, it is difficult to guarantee the uniformity and stability of the quality of the drop pill product. 2. There is no material supply system, and the uniformity of the active ingredient in the drop pill is reduced. 3. Furthermore, it is necessary to adopt a liquid cooling method to perform liquid-solid separation of the drop pills and the cooling liquid, but it is relatively difficult to operate the two liquids completely, Remains in the drop pills and causes contamination of the drop pills. 4. When the production volume needs to be adjusted, the conventional dripping equipment is generally only possible by changing the dripper and adjusting the pressure. The number of drippings is small, and in addition, the surface area is exchanged with a large amount of paraffin coolant. Therefore, the circulation efficiency is low, the energy consumption is large, the equipment volume is increased, the blind spot on the clean surface is likely to exist, and the risk of cross-contamination is great.
従来の滴丸剤製造方法を如何に改良するかにおいては、滴丸剤製造過程における安定性の確保、滴丸剤の成形品質および生産速度の有効な向上、滴丸剤の滴下可能寸法範囲の拡大が含まれ、同時にエネルギー消費および冷却液使用量を低減して、滴丸剤の汚染を防止することが、現在の滴丸剤製造方法の改良の発展傾向および研究方向である。 In order to improve the conventional drop pill manufacturing method, the stability in the drop pill manufacturing process is ensured, the molding quality and production speed of the drop pill are improved effectively, Increasing, while simultaneously reducing energy consumption and coolant usage to prevent contamination of the drop pills is the development trend and research direction of improvements to current drop pill manufacturing methods.
上述の従来技術の欠点および存在する課題に対し、本発明は、液体冷却による滴丸剤のインテリジェント連続製造方法を提供して、全体的な製造過程の経過時間を短縮するだけでなく、滴丸剤製品が安定性および均一性をさらに有するように確保し、かつ高速遠心法を採用することによって合理的に滴丸剤を脱油して、滴丸剤が汚染されることを防止し、冷却液の循環利用率も向上させることを目的とする。 In response to the above-mentioned drawbacks and existing problems of the prior art, the present invention provides an intelligent continuous production method of liquid pills by liquid cooling, not only reducing the elapsed time of the overall production process, To ensure that the product is more stable and uniform, and by adopting a high speed centrifuge, the drop pills can be rationally deoiled to prevent the drop pills from being contaminated and cooled The purpose is to improve the liquid recycling rate.
上述の目的を達成するために、本発明が採用する具体的な技術態様は以下の通りである。
1)複数の材料をそれぞれ秤量して搬送する、材料供給ステップ、
2)ステップ1)で搬送された前記材料を段階的に加熱しかつ混合することによって混合材料が得られ、前記混合材料中の有効成分RSDが5%以下である、材料熔解混合ステップ、
3)ステップ2)で得られた混合材料を加圧および昇温して、有効成分RSDが5%以下である均質化材料が得られる、均質化ステップ、
4)ステップ3)で得られた均質化材料を振動滴下した後に滴丸剤が得られ、滴丸剤を冷却液に投入して冷却した後に搬送する、滴下ステップ、
5)ステップ4)で搬送された滴丸剤の表面の冷却液を傾斜遠心法によって除去する、脱油ステップ
を含む液体冷却による滴丸剤のインテリジェント連続製造方法である。
In order to achieve the above-described object, specific technical aspects adopted by the present invention are as follows.
1) A material supply step for weighing and transporting a plurality of materials,
2) A material melting and mixing step in which a mixed material is obtained by stepwise heating and mixing the material conveyed in step 1), and an active ingredient RSD in the mixed material is 5% or less,
3) A homogenization step in which the mixed material obtained in step 2) is pressurized and heated to obtain a homogenized material having an active ingredient RSD of 5% or less,
4) A drop pill is obtained after vibrationally dropping the homogenized material obtained in step 3), dropping the drop pill into a cooling liquid and transporting it after cooling, a dropping step;
5) This is an intelligent continuous production method of liquid pills by liquid cooling including a deoiling step in which the cooling liquid on the surface of the liquid drops transported in step 4) is removed by a tilted centrifugal method.
さらに、前記ステップ5)において、傾斜遠心法によって除去する際の遠心加速度が500〜2000Gであり、傾斜進み角が40°〜90°であり、滴丸剤の一粒当たりの除去時間が30sを超えず、前記遠心加速度が指向する中心回転軸の方向が水平方向である。すなわち、横型遠心構造を採用する。 Furthermore, in the step 5), the centrifugal acceleration when removing by the inclined centrifugation method is 500 to 2000 G, the inclination advance angle is 40 ° to 90 °, and the removal time per drop pill is 30 s. Without exceeding, the direction of the central rotation axis to which the centrifugal acceleration is directed is the horizontal direction. That is, a horizontal centrifugal structure is adopted.
好ましくは、前記ステップ5)において、傾斜遠心法によって除去する際の遠心加速度が600〜1800Gであり、傾斜進み角が50°〜80°であり、滴丸剤の一粒当たりの除去時間が20sを超えない。 Preferably, in step 5), the centrifugal acceleration upon removal by the tilted centrifuge method is 600 to 1800 G, the tilt advance angle is 50 ° to 80 °, and the removal time per drop pill is 20 s. Not exceed.
さらに、ステップ1)において、前記秤量はロスインウェイト式秤量であり(すなわち、材料の秤量時、加速度が0に近い)、ここで、薬剤と補助材料マトリックスの重量比が1:5〜5:1である。 Furthermore, in step 1), the weighing is a loss-in-weight weighing (that is, the acceleration is close to 0 when the material is weighed), where the weight ratio of the drug to the auxiliary material matrix is 1: 5 to 5: 1.
さらに、ステップ2)において、前記材料の段階的加熱および混合の経過時間は60sを超えず、好ましくは30sを超えず、材料中の固体状態の材料の温度を50±10℃まで加熱した後、材料中の液体状態と混合して混合材料が得られ、55±10℃まで加熱し続け、再び2次混合、脱気、搬送の3つのステップを順に行い、各ステップの温度が0〜10℃上昇する。材料の混合過程が終了したときの温度が80℃以下であり、好ましくは60〜70℃である。 Furthermore, in step 2), the elapsed time of stepwise heating and mixing of the material does not exceed 60 s, preferably does not exceed 30 s, and after heating the temperature of the solid state material in the material to 50 ± 10 ° C., The mixed material is obtained by mixing with the liquid state in the material, and the mixture is continuously heated to 55 ± 10 ° C., and the three steps of secondary mixing, deaeration, and conveyance are performed again in order, and the temperature of each step is 0 to 10 ° C. To rise. The temperature when the mixing process of the materials is completed is 80 ° C. or less, preferably 60 to 70 ° C.
さらに、ステップ3)において、前記混合材料を加圧および昇温することにおいて、加えられる圧力が50〜200MPaであり、好ましくは70〜160MPaであり、温度は10〜20℃上昇する。均質化ステップで加圧および昇温を完了した後に温度が80〜100℃、好ましくは90〜95℃に達することができる。均質化装置の出口圧力が0.005〜0.5MPaであり、好ましくは0.1〜2MPaである。 Furthermore, in step 3), in pressurizing and raising the temperature of the mixed material, the applied pressure is 50 to 200 MPa, preferably 70 to 160 MPa, and the temperature rises by 10 to 20 ° C. The temperature can reach 80-100 ° C., preferably 90-95 ° C. after completing the pressurization and temperature rise in the homogenization step. The outlet pressure of the homogenizer is 0.005 to 0.5 MPa, preferably 0.1 to 2 MPa.
さらに、ステップ4)において、前記振動滴下は、その振動周波数が10〜500Hzであり、好ましくは30〜200Hzであり、均質化装置の出口圧力を調整することにより、滴下する滴丸剤の直径を1〜10mm、好ましくは1〜5mmに制御することができる。 Furthermore, in step 4), the vibration dropping has a vibration frequency of 10 to 500 Hz, preferably 30 to 200 Hz, and the diameter of the dropped pill is adjusted by adjusting the outlet pressure of the homogenizer. It can be controlled to 1 to 10 mm, preferably 1 to 5 mm.
さらに、ステップ4)において、前記冷却液が温度勾配を有し、範囲が−15〜60℃であり、好ましくは0〜50℃であり、滴丸剤が高温箇所から低温箇所へと冷却液を通過する。バレル底部の冷却液の初期温度は−15〜25℃である。バレル中の冷却液の液面が上昇するにつれ、温度も下から上へ漸次上昇して、一つの温度勾配が形成され、勾配範囲は−15〜60℃である。 Further, in step 4), the cooling liquid has a temperature gradient, the range is -15 to 60 ° C, preferably 0 to 50 ° C, and the drop pill removes the cooling liquid from the hot spot to the cold spot. pass. The initial temperature of the coolant at the bottom of the barrel is -15 to 25 ° C. As the liquid level of the coolant in the barrel rises, the temperature gradually rises from the bottom to the top, forming a temperature gradient with a gradient range of -15-60 ° C.
さらに、ステップ4)において、前記冷却液は、パラフィン、メチルシリコーン油、ケロシンなどを含み、好ましくは流動パラフィンである。 Further, in step 4), the cooling liquid includes paraffin, methyl silicone oil, kerosene, and the like, preferably liquid paraffin.
さらに、前記ステップ4)の前記振動滴下および冷却の経過時間が60sを超えず、好ましくは30sを超えない。 Further, the elapsed time of the vibration dropping and cooling in the step 4) does not exceed 60 s, and preferably does not exceed 30 s.
さらに、複数の材料は薬剤および補助材料マトリックスを含み、前記薬剤は、サイコ、タンジン、チセン、カッコウ、センシンレン抽出物の中から選ばれる1種またはタンジン複合物の抽出物であり、好ましくはタンジン複合物の抽出物である。さらに、複合物製剤は市販のチセンイキ滴丸剤、カッコウショウキ滴丸剤、またはタンジン複合物滴丸剤のような有効成分から選ばれることができ、好ましくはタンジン複合物滴丸剤の有効成分であり、前記補助材料マトリックスは、ポリエチレングリコール類、ソルビトール、キシリトール、ラクチトール、マルトース、デンプン、メチルセルロース、カルボキシメチルセルロース、ヒドロキシプロピルメチルセルロース、アラビアゴム、アルギン酸、デキストリン、シクロデキストリン、寒天、ラクトースの中から選ばれる1種以上である。好ましくはポリエチレングリコールである。 Further, the plurality of materials includes a drug and an auxiliary material matrix, wherein the drug is an extract of one or a tandin complex selected from psycho, tandin, thixene, cuckoo, and sensinren extracts, preferably a tandin complex. It is a product extract. In addition, the composite formulation can be selected from active ingredients such as commercially available Chisen Iki drop, Cuckoo pepper drop pills, or Tandin complex drop pills, preferably an active ingredient of Tandin complex drop pills. The auxiliary material matrix is selected from polyethylene glycols, sorbitol, xylitol, lactitol, maltose, starch, methylcellulose, carboxymethylcellulose, hydroxypropylmethylcellulose, gum arabic, alginic acid, dextrin, cyclodextrin, agar, lactose 1 More than a seed. Polyethylene glycol is preferred.
上述の技術態様の説明から分かるように、本発明の方法の各ステップは緊密に結び付いており、連続式作業であり、バッチに柔軟性があり、バッチ間の製品品質が均一で、安定しており、生産性が高く、材料の残留物が少なく、滴丸剤の全製造時間が3min未満であり、従来技術における、原料中に含まれる一部の揮発性成分による成分の揮発や、品質が不安定であるという短所を克服した。本発明の方法を用いて製造された滴丸剤は、品質の一貫性に優れ、ロスインウェイト式秤量を採用することによって、用量精度が0.5‰に達することができる。 As can be seen from the above description of the technical aspects, the steps of the method of the present invention are closely linked, are continuous operations, are flexible in batches, have uniform product quality between batches, and are stable. It has high productivity, low material residue, and the total production time of drop pills is less than 3 min. In the prior art, the volatilization of components due to some volatile components contained in the raw materials and the quality are low. Overcame the disadvantage of being unstable. The drop pill produced using the method of the present invention has excellent quality consistency, and the dose accuracy can reach 0.5 ‰ by adopting a loss-in-weight weighing.
さらに、均質化材料の出口圧力を制御することによって、滴丸剤の大きさを調整でき、滴下過程において用いられるドリッパーを変更する必要がなく、製品の仕様を調整しやすい。 Furthermore, by controlling the outlet pressure of the homogenizing material, the size of the drop pill can be adjusted, and it is not necessary to change the dripper used in the dropping process, and it is easy to adjust the product specifications.
本発明の上述の特徴および長所をより明確かつ分かりやすくするために、以下に実施例を挙げて詳しく説明する。 In order to make the above features and advantages of the present invention clearer and easier to understand, the following detailed description will be given by way of examples.
実施例1 タンジン複合物滴丸剤の製造
タンジンサンシチニンジン抽出物600g、ボルネオール5g、およびPEG−6000補助材料2000gを取り、それぞれ精密に秤量した後、ボルネオールとPEG−6000を先に加熱して材料を混合して、温度を55℃まで加熱し、かつタンジンサンシチニンジン抽出物とさらに混合し、60℃まで加熱し続け、混合材料に対して混合、脱気、搬送などのステップを引き続き行った後、最終温度は65℃に達し、上述の材料の混合過程の時間は60sを超えなかった。均質圧力を2000MPaに調整し、混合材料をさらに均一に分散させてナノレベル分散に達し、かつ材料の温度がさらに上昇し、均質化装置の出口において、混合材料の温度は80℃であり、均質化装置の出口圧力は2MPaであった。混合材料をドリッパーの振動によって滴下し、振動周波数を50Hzに調整し、材料を流動パラフィンが装填されたバレルに滴下投入し、ドリッパーから流動パラフィン液面の頂端までの距離は300mmであり、バレルの高さは5mであり、バレルの直径は100mmであり、流動パラフィンの入口の初期温度は−10℃であり、バレルにおいて下から上へ一つの温度勾配が形成され、勾配範囲は−10〜50℃であり、材料を流動パラフィン中に滴下投入した後、温度の作用で、十分な冷却によって滴下された材料が固体状態の滴丸剤に冷却され、滴下された滴丸剤の直径は5mmであり、上述の滴下過程の時間は60sを超えなかった。滴丸剤が形成された後、流動パラフィンと共にふるいを介して最初のろ過を行った後に脱油ステップを行った。脱油装置は水平に置かれた遠心機であり、加速度2000Gの条件で、滴丸剤とパラフィン油の分離を行い、最終的にコーティングしていないタンジン複合物が得られ、上述の脱油過程の時間は30sを超えなかった。次にコーティングなどの操作を行うことができる。
Example 1 Preparation of Tanjin Complex Drop Pills Tanjin Sancytinjin extract 600 g, Borneol 5 g, and PEG-6000 auxiliary material 2000 g were each weighed precisely and then borneol and PEG-6000 were heated first. Mix the materials, heat the temperature to 55 ° C, and further mix with the tanjin sanchinin ginseng extract, continue to heat to 60 ° C and continue the steps of mixing, degassing, conveying etc. to the mixed material After that, the final temperature reached 65 ° C. and the mixing process time of the above materials did not exceed 60 s. The homogenous pressure is adjusted to 2000 MPa, the mixed material is further uniformly dispersed to reach nano-level dispersion, and the temperature of the material is further increased, and at the outlet of the homogenizer, the temperature of the mixed material is 80 ° C. The outlet pressure of the gasifier was 2 MPa. The mixed material is dropped by dripper vibration, the vibration frequency is adjusted to 50 Hz, the material is dropped into the barrel loaded with liquid paraffin, the distance from the dripper to the top of the liquid paraffin liquid surface is 300 mm, The height is 5 m, the diameter of the barrel is 100 mm, the initial temperature of the liquid paraffin inlet is −10 ° C., a temperature gradient is formed in the barrel from bottom to top, the gradient range is −10 to 50 After the material is dropped into liquid paraffin at a temperature of 0 ° C., the material dripped by sufficient cooling is cooled to a solid state pill by the effect of temperature, and the diameter of the dropped pill is 5 mm. Yes, the time for the dropping process described above did not exceed 60 s. After the drop pills were formed, the first oil was filtered through a sieve with liquid paraffin, followed by a deoiling step. The deoiler is a centrifuge placed horizontally, separating pills and paraffin oil under the condition of an acceleration of 2000G, and finally obtaining an uncoated tangin composite. The time did not exceed 30 s. Next, operations such as coating can be performed.
上述の製造方法を用いて生産プロセスを設定することにより、全設備の生産性が100kg/hに達し、材料の残留物が5kg未満になり、材料が設備を通過する時間を3min未満にすることができ、材料供給精度を0.5%に制御して、用量精度が0.5‰に達することができる。 By setting the production process using the manufacturing method described above, the productivity of all equipment reaches 100 kg / h, the material residue is less than 5 kg, and the time for the material to pass through the equipment is less than 3 min. The material supply accuracy can be controlled to 0.5%, and the dose accuracy can reach 0.5 ‰.
実施例2 タンジン複合物滴丸剤の製造
タンジンサンシチニンジン抽出物600g、ボルネオール5g、およびPEG−6000補助材料3000gを取り、それぞれ精密に秤量した後、ボルネオールとPEG−6000を先に加熱して材料を混合して、温度を50℃まで加熱し、かつタンジンサンシチニンジン抽出物とさらに混合し、55℃まで加熱し続け、混合材料に対して混合、脱気、搬送などのステップを引き続き行った後、最終温度は70℃に達し、上述の材料の混合過程の時間は30sを超えなかった。均質圧力を1500MPaに調整し、混合材料をさらに均一に分散させてナノレベル分散に達し、かつ材料の温度がさらに上昇し、均質化装置の出口において、混合材料の温度は90℃であり、均質化装置の出口圧力は0.1MPaであった。混合材料をドリッパーの振動によって滴下し、振動周波数を500Hzに調整し、材料を流動パラフィンが装填されたバレルに滴下投入し、ドリッパーから流動パラフィン液面の頂端までの距離は1000mmであり、バレルの高さは10mであり、バレルの直径は1000mmであり、流動パラフィンの入口の初期温度は0℃であり、バレルにおいて下から上へ一つの温度勾配が形成され、勾配範囲は0〜60℃であり、材料を流動パラフィン中に滴下投入した後、温度の作用で、十分な冷却によって滴下された材料が固体状態の滴丸剤に冷却され、滴下された滴丸剤の直径は2mmであり、上述の滴下過程の時間は30sを超えなかった。滴丸剤が形成された後、流動パラフィンと共にふるいを介して最初のろ過を行った後に脱油ステップを行った。脱油装置は、水平に置かれた遠心機であり、加速度1500Gの条件で、滴丸剤とパラフィン油の分離を行い、最終的にコーティングしていないタンジン複合物が得られ、上述の脱油過程の時間は20sを超えなかった。次にコーティングなどの操作を行うことができる。
Example 2 Manufacture of Tandin Complex Drop Pills Take 600 g of Tandin Sancytinine extract, 5 g of borneol, and 3000 g of PEG-6000 auxiliary material and weigh each precisely, then heat borneol and PEG-6000 first. Mix the materials, heat the temperature to 50 ° C, and further mix with the tanjin sanchinin ginseng extract, continue to heat to 55 ° C and continue the steps of mixing, degassing, conveying etc. to the mixed material After that, the final temperature reached 70 ° C. and the mixing process time of the above materials did not exceed 30 s. The homogenous pressure is adjusted to 1500 MPa, the mixed material is further uniformly dispersed to reach nano-level dispersion, and the temperature of the material is further increased, and at the outlet of the homogenizer, the temperature of the mixed material is 90 ° C. The outlet pressure of the gasifier was 0.1 MPa. The mixed material is dropped by dripper vibration, the vibration frequency is adjusted to 500 Hz, the material is dropped into the barrel filled with liquid paraffin, the distance from the dripper to the top of the liquid paraffin liquid level is 1000 mm, The height is 10 m, the diameter of the barrel is 1000 mm, the initial temperature of the liquid paraffin inlet is 0 ° C., a temperature gradient is formed in the barrel from bottom to top, the gradient range is 0-60 ° C. Yes, after dropping the material into liquid paraffin, due to the effect of temperature, the material dropped by sufficient cooling is cooled to a solid pill, the diameter of the dropped pill is 2 mm, The time of the dropping process described above did not exceed 30 s. After the drop pills were formed, the first oil was filtered through a sieve with liquid paraffin, followed by a deoiling step. The deoiling device is a horizontally placed centrifuge, which separates the drop pills and paraffin oil under the condition of an acceleration of 1500G, and finally obtains an uncoated tangin composite. The process time did not exceed 20 s. Next, operations such as coating can be performed.
上述の製造方法を用いて生産プロセスを設定することにより、全設備の生産性が120kg/hに達し、材料の残留物が5.5kg未満になり、材料が設備を通過する時間を2min未満にすることができ、材料供給精度を0.5%に制御して、用量精度が0.6‰に達することができる。 By setting the production process using the manufacturing method described above, the productivity of all equipment reaches 120 kg / h, the material residue is less than 5.5 kg, and the time for the material to pass through the equipment is less than 2 min. The material supply accuracy can be controlled to 0.5%, and the dose accuracy can reach 0.6 ‰.
実施例3 カッコウショウキ滴丸剤の製造
カッコウショウキ抽出物200g、パチョリ油1ml、エゴマ葉油2ml、ポリエチレングリコール40gを取り、それぞれ精密に秤量した後、ポリエチレングリコールを先に加熱して材料を混合して、温度を45℃まで加熱し、かつカッコウショウキ抽出物、パチョリ油、エゴマ葉油とさらに混合し、55℃まで加熱し続け、混合材料に対して混合、脱気、搬送などのステップを引き続き行った後、最終温度は70℃に達し、上述の材料の混合過程の時間は60sを超えなかった。均質圧力を500MPaに調整し、混合材料をさらに均一に分散させてナノレベル分散に達し、かつ材料の温度がさらに上昇し、均質化装置の出口において、混合材料の温度は80℃であり、均質化装置の出口圧力は0.05MPaであった。混合材料をドリッパーの振動によって滴下し、振動周波数を100Hzに調整し、材料を流動パラフィンが装填されたバレルに滴下投入し、ドリッパーから流動パラフィン液面の頂端までの距離は700mmであり、バレルの高さは8mであり、バレルの直径は100mmであり、流動パラフィンの入口の初期温度は5℃であり、バレルにおいて下から上へ一つの温度勾配が形成され、勾配範囲は5〜60℃であり、材料を流動パラフィン中に滴下投入した後、温度の作用で、十分な冷却によって滴下された材料が固体状態の滴丸剤に冷却され、滴下された滴丸剤の直径は1mmであり、上述の滴下過程の時間は50sを超えなかった。滴丸剤が形成された後、流動パラフィンと共にふるいを介して最初のろ過を行った後に脱油ステップを行った。脱油装置は水平に置かれた遠心機であり、加速度500Gの条件で、滴丸剤とパラフィン油の分離を行い、最終的にコーティングしていないカッコウショウキが得られ、上述の脱油過程の時間は25sを超えなかった。次にコーティングなどの操作を行うことができる。
Example 3 Manufacture of Cuckoo Pepper Drop Pills 200 g of Cuckoo Pepper extract, 1 ml of patchouli oil, 2 ml of sesame leaf oil, and 40 g of polyethylene glycol were weighed accurately and then each was precisely weighed, and then the polyethylene glycol was first heated to mix the materials. The temperature is increased to 45 ° C., and further mixed with Cuckoo extract, patchouli oil, sesame leaf oil, and heated to 55 ° C., and the steps of mixing, degassing, conveying, etc. are continued for the mixed material. After doing so, the final temperature reached 70 ° C. and the mixing process time of the above materials did not exceed 60 s. The homogenous pressure is adjusted to 500 MPa, the mixed material is more uniformly dispersed to reach nano-level dispersion, and the temperature of the material is further increased, and at the outlet of the homogenizer, the temperature of the mixed material is 80 ° C. The outlet pressure of the gasifier was 0.05 MPa. The mixed material is dropped by dripper vibration, the vibration frequency is adjusted to 100 Hz, the material is dropped into a barrel loaded with liquid paraffin, the distance from the dripper to the top of the liquid paraffin liquid surface is 700 mm, The height is 8 m, the diameter of the barrel is 100 mm, the initial temperature of the liquid paraffin inlet is 5 ° C., a temperature gradient is formed in the barrel from bottom to top, the gradient range is 5-60 ° C. Yes, after dropping the material into liquid paraffin, due to the effect of temperature, the material dropped by sufficient cooling is cooled to a solid pill, the diameter of the dropped pill is 1 mm, The time for the dropping process described above did not exceed 50 s. After the drop pills were formed, the first oil was filtered through a sieve with liquid paraffin, followed by a deoiling step. The deoiling device is a centrifuge placed horizontally, separating pills and paraffin oil under the condition of acceleration of 500G, and finally obtaining uncoated cuckoo pepper, The time did not exceed 25s. Next, operations such as coating can be performed.
上述の製造方法を用いて生産プロセスを設定することにより、全設備の生産性が95kg/hに達し、材料の残留物が4.5kg未満になり、材料が設備を通過する時間を3min未満にすることができ、材料供給精度を0.55%に制御して、用量精度が0.5‰に達することができる。 By setting the production process using the manufacturing method described above, the productivity of all equipment reaches 95 kg / h, the material residue is less than 4.5 kg, and the time for the material to pass through the equipment is less than 3 min. The dose accuracy can reach 0.5 ‰ by controlling the material supply accuracy to 0.55%.
実施例4 センシンレン滴丸剤の製造
センシンレン400g、PEG−6000補助材料800g、PEG−4000補助材料800gを取り、それぞれ精密に秤量した後、センシンレンと、PEG−6000と、PEG−4000とを先に加熱して材料を混合して、温度を55℃まで加熱し、混合材料に対して混合、脱気、搬送などのステップを引き続き行った後、最終温度は70℃に達し、上述の材料の混合過程の時間は45sを超えなかった。均質圧力を1500MPaに調整し、混合材料をさらに均一に分散させてナノレベル分散に達し、かつ材料の温度がさらに上昇し、均質化装置の出口において、混合材料の温度は90℃であり、均質化装置の出口圧力は5MPaであった。混合材料をドリッパーの振動によって滴下し、振動周波数を300Hzに調整し、材料を流動パラフィンが装填されたバレルに滴下投入し、ドリッパーから流動パラフィン液面の頂端までの距離は300mmであり、バレルの高さは1mであり、バレルの直径は500mmであり、流動パラフィンの入口の初期温度は0℃であり、バレルにおいて下から上へ一つの温度勾配が形成され、勾配範囲は0〜60℃であり、材料を流動パラフィン中に滴下投入した後、温度の作用で、十分な冷却によって滴下された材料が固体状態の滴丸剤に冷却され、滴下された滴丸剤の直径は10mmであり、上述の滴下過程の時間は55sを超えなかった。滴丸剤が形成された後、流動パラフィンと共にふるいを介して最初のろ過を行った後に脱油ステップを行った。脱油装置は水平に置かれた遠心機であり、加速度500Gの条件で、滴丸剤とパラフィン油の分離を行い、最終的にコーティングしていないセンシンレンが得られ、上述の脱油過程の時間は25sを超えなかった。次にコーティングなどの操作を行うことができる。
Example 4 Production of Senshinren Drop Pills 400 g of sensinlen, 800 g of PEG-6000 auxiliary material and 800 g of PEG-4000 auxiliary material were weighed and precisely weighed. After mixing the materials by heating, the temperature is heated to 55 ° C, and after the steps of mixing, degassing, conveying, etc. are continuously performed on the mixed materials, the final temperature reaches 70 ° C, and the above-mentioned materials are mixed The process time did not exceed 45 s. The homogenous pressure is adjusted to 1500 MPa, the mixed material is further uniformly dispersed to reach nano-level dispersion, and the temperature of the material is further increased, and at the outlet of the homogenizer, the temperature of the mixed material is 90 ° C. The outlet pressure of the gasifier was 5 MPa. The mixed material is dropped by dripper vibration, the vibration frequency is adjusted to 300 Hz, the material is dropped into the barrel filled with liquid paraffin, the distance from the dripper to the top of the liquid paraffin liquid surface is 300 mm, The height is 1 m, the diameter of the barrel is 500 mm, the initial temperature of the liquid paraffin inlet is 0 ° C., one temperature gradient is formed in the barrel from bottom to top, the gradient range is 0-60 ° C. Yes, after dropping the material into liquid paraffin, due to the effect of temperature, the material dripped by sufficient cooling is cooled to a solid pill, the diameter of the dropped pill is 10 mm, The time for the dropping process described above did not exceed 55 s. After the drop pills were formed, the first oil was filtered through a sieve with liquid paraffin, followed by a deoiling step. The deoiling device is a centrifuge placed horizontally, separating pills and paraffin oil under the condition of acceleration of 500G, and finally obtaining uncoated senshinren, the time for the above deoiling process Did not exceed 25 s. Next, operations such as coating can be performed.
上述の製造方法を用いて生産プロセスを設定することにより、全設備の生産性が110kg/hに達し、材料の残留物を5.2kg未満にし、材料が設備を通過する時間を2.5min未満にすることができ、材料供給精度を0.6%に制御して、用量精度が0.55‰に達することができる。 By setting the production process using the above manufacturing method, the productivity of all equipment reaches 110 kg / h, the material residue is less than 5.2 kg, and the time for the material to pass through the equipment is less than 2.5 min The material supply accuracy can be controlled to 0.6% and the dose accuracy can reach 0.55 ‰.
比較例
従来の滴丸剤の滴下:中国特許ZL200810153713.6に開示されている滴丸剤機の生産ラインを用いて、タンジン複合物滴丸剤を製造した。
以下に、本発明が従来の滴丸剤の製造方法に比べてさらに優位性を有することを表により説明する。
Comparative Example Conventional drop pill dripping: Tandin composite drop pills were produced using a drop pill machine production line disclosed in Chinese Patent ZL20081015133713.6.
Below, it demonstrates with a table | surface that this invention has a further advantage compared with the manufacturing method of the conventional drop pill.
上述の実施例および比較例から分かるように、本発明は、全体的な製造過程の経過時間を短縮するだけでなく、滴丸剤製品がさらに安定性を有するように確保し、安定的な材料供給精度および用量精度を有することを保証する。また、高速遠心法を採用することによって合理的に滴丸剤を脱油して、滴丸剤が汚染されることを防止し、パラフィン冷却液の循環利用率も向上させる。 As can be seen from the above examples and comparative examples, the present invention not only shortens the elapsed time of the overall manufacturing process, but also ensures that the drop pill product is more stable and stable material. Guarantee having feeding accuracy and dosage accuracy. Moreover, by adopting a high-speed centrifugation method, the pills are rationally deoiled to prevent the pills from being contaminated, and the circulation utilization rate of the paraffin coolant is improved.
Claims (11)
2)ステップ1)で搬送された前記材料を段階的に加熱しかつ混合することによって混合材料が得られ、前記混合材料中の有効成分RSDが5%以下である、材料熔解混合ステップと、
3)ステップ2)で得られた混合材料を加圧および昇温して、有効成分RSDが5%以下である均質化材料が得られる、均質化ステップと、
4)ステップ3)で得られた均質化材料を振動滴下した後に滴丸剤が得られ、滴丸剤を冷却液に投入して冷却した後に搬送する、滴下ステップと、
5)ステップ4)で搬送された滴丸剤の表面の冷却液を傾斜遠心法によって除去する、脱油ステップと
を含む液体冷却による滴丸剤のインテリジェント連続製造方法。 1) a material supply step for weighing and transporting a plurality of materials,
2) A material melting and mixing step in which a mixed material is obtained by stepwise heating and mixing the material conveyed in step 1), and an active ingredient RSD in the mixed material is 5% or less;
3) A homogenization step in which the mixed material obtained in step 2) is pressurized and heated to obtain a homogenized material having an active ingredient RSD of 5% or less;
4) A dropping step in which a drop pill is obtained after the homogenized material obtained in step 3) is vibrated and dropped, and the drop pill is put into a cooling liquid and cooled and then transported;
5) An intelligent continuous production method of liquid drop pills by liquid cooling, including a deoiling step, wherein the cooling liquid on the surface of the liquid drop pills conveyed in step 4) is removed by an inclined centrifugal method.
前記補助材料マトリックスは、ポリエチレングリコール類、ソルビトール、キシリトール、ラクチトール、マルトース、デンプン、メチルセルロース、カルボキシメチルセルロース、ヒドロキシプロピルメチルセルロース、アラビアゴム、アルギン酸、デキストリン、シクロデキストリン、寒天、ラクトースの中から選ばれる1種以上であることを特徴とする請求項1に記載の液体冷却による滴丸剤のインテリジェント連続製造方法。 The plurality of materials includes a drug and an auxiliary material matrix, wherein the drug is an extract of one or a tangin complex selected from psycho, tandin, chicene, cuckoo, sensinren extracts, or a commercially available Selected from the active ingredients of Chisen Iki Droplet, Cuckoo Shower Droplet or Tanjin Complex Drop Pill,
The auxiliary material matrix is at least one selected from polyethylene glycols, sorbitol, xylitol, lactitol, maltose, starch, methylcellulose, carboxymethylcellulose, hydroxypropylmethylcellulose, gum arabic, alginic acid, dextrin, cyclodextrin, agar, and lactose. The intelligent continuous manufacturing method of the drop pill by liquid cooling of Claim 1 characterized by these.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510598591.1 | 2015-09-18 | ||
CN201510598591 | 2015-09-18 | ||
PCT/CN2016/099018 WO2017045609A1 (en) | 2015-09-18 | 2016-09-14 | Intelligent continuous manufacturing method via liquid cooling of dripping pills |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018527103A true JP2018527103A (en) | 2018-09-20 |
JP6842460B2 JP6842460B2 (en) | 2021-03-17 |
Family
ID=58288158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018513526A Active JP6842460B2 (en) | 2015-09-18 | 2016-09-14 | Continuous production method of drop pills by liquid cooling |
Country Status (11)
Country | Link |
---|---|
US (1) | US10813840B2 (en) |
EP (1) | EP3351234B1 (en) |
JP (1) | JP6842460B2 (en) |
CN (2) | CN106539690B (en) |
AU (1) | AU2016322412B2 (en) |
CA (1) | CA2995723C (en) |
NZ (1) | NZ740289A (en) |
RU (1) | RU2722735C2 (en) |
TW (1) | TWI692355B (en) |
WO (1) | WO2017045609A1 (en) |
ZA (1) | ZA201802083B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105983016B (en) | 2015-03-23 | 2023-08-11 | 天士力医药集团股份有限公司 | A pharmaceutical composition containing silybin |
CN109331738B (en) * | 2018-08-13 | 2024-03-15 | 昆明旭邦机械有限公司 | Integrated dripping pill machine |
CN112920780B (en) * | 2021-01-27 | 2022-08-30 | 上海烟草集团有限责任公司 | Oily cooling liquid for preparing high-density essence blasting beads, application of oily cooling liquid and preparation method of high-density essence blasting beads |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITVE20000013U1 (en) * | 2000-06-29 | 2001-12-29 | Hydor Srl | THERMOSTATIC HEATER FOR LIQUIDS EQUIPPED WITH RECIRCULATION PUMP. |
CN1357412A (en) * | 2000-12-08 | 2002-07-10 | 天津理工学院 | Chinese medicine dripping pill defatting centrifuga |
US8486464B2 (en) | 2000-12-22 | 2013-07-16 | Tasly Pharmaceutical Group Co. Ltd. | Herbal composition for angina pectoris, method to prepare same and uses thereof |
CN100444819C (en) * | 2004-08-10 | 2008-12-24 | 北京正大绿洲医药科技有限公司 | New technique for preparing drop pills and special dripper device |
US7662412B2 (en) * | 2005-07-18 | 2010-02-16 | Laiwang Guo | Traditional Chinese medicine composition to treat rheumatoid arthritis and preparation method thereof |
CN100482254C (en) * | 2006-01-12 | 2009-04-29 | 哈尔滨三乐生物工程有限公司 | Method for extracting effective site of Xanthoceras sorbifolia hulled seed |
CN101214242A (en) * | 2007-01-05 | 2008-07-09 | 上海艾力斯医药科技有限公司 | Novel pharmaceutical composition |
CN101318162A (en) * | 2007-06-04 | 2008-12-10 | 烟台开发区博森制药机械有限公司 | Horizontal centrifugal |
CN201042679Y (en) | 2007-06-04 | 2008-04-02 | 烟台开发区博森制药机械有限公司 | Horizontal centrifugal |
CN101279220B (en) * | 2007-12-28 | 2011-06-08 | 天津天士力制药股份有限公司 | Method for preparing dropping pill using cool air and equipment using the method |
CN101224198A (en) | 2008-02-04 | 2008-07-23 | 云南省药物研究所 | Preparing method of breviscapinun dropping pills |
CN101744722B (en) * | 2008-12-03 | 2013-09-11 | 天士力制药集团股份有限公司 | Dripping pill production line |
CN101745472B (en) * | 2008-12-03 | 2015-05-06 | 天士力制药集团股份有限公司 | Cylinder body of centrifugal machine and centrifugal machine with cylinder body |
CN201350218Y (en) * | 2008-12-03 | 2009-11-25 | 天津天士力制药股份有限公司 | Dripping pill production line |
CN101574305B (en) * | 2009-06-12 | 2013-05-08 | 天津大学 | Vibration-crushing micro-pill machine |
CN101703487A (en) | 2009-12-04 | 2010-05-12 | 山西医科大学 | Codonopsis pilosula polysaccharide pill |
CN102160872A (en) * | 2010-02-23 | 2011-08-24 | 天津天士力制药股份有限公司 | Compound salvia dropping pill capsules |
EP2409583B1 (en) * | 2010-07-21 | 2015-04-22 | Universidad Autònoma de Barcelona | Continuous system and procedure of sterilization and physical stabilization of pumpable fluids by means of ultra-high pressure homogenization |
CN102988420B (en) | 2012-08-23 | 2014-06-25 | 耿福能 | Nano periplaneta americana product as well as preparation method and application thereof |
US9839921B2 (en) * | 2013-03-14 | 2017-12-12 | Sisu Global Health, Inc. | Modular centrifuge devices and methods |
CN104274319A (en) * | 2013-07-11 | 2015-01-14 | 天士力制药集团股份有限公司 | Method for dropping drop pills by vibration |
WO2015003662A1 (en) | 2013-07-11 | 2015-01-15 | 天士力制药集团股份有限公司 | Traditional chinese medicine composition, and preparation and application thereof |
CN104274322A (en) * | 2013-07-11 | 2015-01-14 | 天士力制药集团股份有限公司 | Method for preparing drop pill by high-speed vibration in dropping way |
CN203710386U (en) * | 2014-02-09 | 2014-07-16 | 南昌弘益科技有限公司 | Pill dropping machine |
TWM479758U (en) * | 2014-02-20 | 2014-06-11 | Timing Pharmaceutical Co Ltd | Improved drop pill |
CN104069170B (en) * | 2014-06-27 | 2017-11-10 | 上海雷允上药业有限公司 | A kind of leaves of pulse plants courage method for preparing drop pills |
CN104523623A (en) | 2014-12-14 | 2015-04-22 | 天津市康瑞药业有限公司 | Apixaban dropping pill and preparation method thereof |
US9439867B1 (en) * | 2015-03-13 | 2016-09-13 | Timing Pharmaceutical Co., Ltd. | Method for manufacturing a compound danshen dripping pill |
CN106539689B (en) * | 2015-09-18 | 2020-05-22 | 天士力医药集团股份有限公司 | Intelligent pill dropping machine capable of continuously solidifying liquid |
-
2016
- 2016-09-07 CN CN201610807442.6A patent/CN106539690B/en active Active
- 2016-09-14 CN CN201680053033.XA patent/CN108024909B/en active Active
- 2016-09-14 US US15/760,367 patent/US10813840B2/en active Active
- 2016-09-14 JP JP2018513526A patent/JP6842460B2/en active Active
- 2016-09-14 AU AU2016322412A patent/AU2016322412B2/en active Active
- 2016-09-14 TW TW105129960A patent/TWI692355B/en active
- 2016-09-14 EP EP16845723.2A patent/EP3351234B1/en active Active
- 2016-09-14 RU RU2018109542A patent/RU2722735C2/en active
- 2016-09-14 CA CA2995723A patent/CA2995723C/en active Active
- 2016-09-14 WO PCT/CN2016/099018 patent/WO2017045609A1/en active Application Filing
- 2016-09-14 NZ NZ740289A patent/NZ740289A/en unknown
-
2018
- 2018-03-28 ZA ZA2018/02083A patent/ZA201802083B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20180256450A1 (en) | 2018-09-13 |
AU2016322412B2 (en) | 2020-08-13 |
RU2018109542A3 (en) | 2019-12-30 |
ZA201802083B (en) | 2021-07-28 |
EP3351234A4 (en) | 2019-05-08 |
RU2018109542A (en) | 2019-09-19 |
CN108024909A (en) | 2018-05-11 |
EP3351234B1 (en) | 2020-10-28 |
JP6842460B2 (en) | 2021-03-17 |
AU2016322412A1 (en) | 2018-03-08 |
US10813840B2 (en) | 2020-10-27 |
CN106539690B (en) | 2020-08-04 |
WO2017045609A1 (en) | 2017-03-23 |
RU2722735C2 (en) | 2020-06-04 |
CN106539690A (en) | 2017-03-29 |
CA2995723C (en) | 2024-04-02 |
CA2995723A1 (en) | 2017-03-23 |
NZ740289A (en) | 2023-06-30 |
EP3351234A1 (en) | 2018-07-25 |
TWI692355B (en) | 2020-05-01 |
CN108024909B (en) | 2020-07-10 |
TW201717887A (en) | 2017-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6748196B2 (en) | Drop Pill Making Machine for Continuous Liquid Coagulation | |
JP2018527103A (en) | Intelligent continuous production method of drop pills by liquid cooling | |
US20160074938A1 (en) | Production method for three-dimensional shaped article | |
CN104274322A (en) | Method for preparing drop pill by high-speed vibration in dropping way | |
JP2005525216A (en) | Apparatus and method for preparing crystalline particles | |
CN203155113U (en) | Vibrating powder dispersing and spreading device for powder supply | |
CN106265780A (en) | Bilobanone ester dropping pills and preparation method thereof, system | |
CN101721476B (en) | Blood sugar lowering mulberry and chrysanthemum granules and preparation method thereof | |
CN105342857A (en) | Equipment for preparing traditional Chinese medicine dropping pills | |
CN109350633A (en) | A kind of Saussurea involucrata culture dripping pill and preparation method thereof | |
CN104274517B (en) | Vibratory drilling method prepares stilbene ginseng QI invigorating droplet ball | |
IT201600119933A1 (en) | Molding system for abrasive discs with weight filling | |
CN102334915B (en) | Device for tempering | |
CN102038696A (en) | Method for preparing compound glycyrrhizin dripping pills | |
CN1857340A (en) | Total seabuckthron flavone dripping pill and its preparing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20180313 |
|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20180313 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190612 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200710 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200721 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200918 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210209 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210219 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6842460 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |